Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 oct. 2025 08h11 HE | Source: Myrtelle

Myrtelle Announces Nature Medicine Publication of Interim Results from Its Phase 1/2 Clinical Trial of Investigational Gene Therapy rAAV-Olig001-ASPA for Canavan Disease

Groundbreaking study demonstrates that targeted oligodendrocyte gene therapy leads to decreased N-acetylaspartate (NAA) levels and increased brain myelin.
01 nov. 2017 09h34 HE | Source: National Tay-Sachs & Allied Diseases Association

National Tay-Sachs & Allied Diseases Association to Hold 60th Anniversary Imagine & Believe Benefit November 9, 2017

BOSTON, Nov. 01, 2017 (GLOBE NEWSWIRE) -- The National Tay-Sachs & Allied Diseases Association (NTSAD), the nation’s longest standing patient advocacy organization, announces that it will honor...
16 oct. 2013 09h55 HE | Source: National Tay-Sachs & Allied Diseases Association

National Tay-Sachs & Allied Diseases Association Forms Jacob's Cure Fund for Canavan Disease Research

BOSTON, Oct. 16, 2013 (GLOBE NEWSWIRE) -- National Tay-Sachs & Allied Diseases Association (NTSAD) today announced that it is forming the Jacob's Cure Fund to support research and family services in...